index  
coursenewsroomcompanycontact

 
  Product Description and Benefits
  Product Makeup/Histology
  Clinical Sequence
  Case Studies
  Summary
   


Use in Burn and Reconstructive Surgery
Previous Previous | Next Next

In 1996, the US Food and Drug Administration (FDA) approved the use of INTEGRA Dermal Regeneration Template for the treatment of life threatening burn injuries. Since then, nearly 10,000 patients have been successfully treated using the INTEGRA Dermal Regeneration Template.

In 2002, the FDA approved the use of INTEGRA Dermal Regeneration Template to include the reconstruction of scar contractures. This new indication provides relief for thousands of individuals living with disabling scarring from prior burns.

In 2014, the FDA approved the use of Integra Meshed Dermal Regeneration Template for the treatment of life threatening burn injuries and the reconstruction of scar contractures.

Indications for Use - U.S.A.

Burns

INTEGRA Template is indicated for the post-excisional treatment of life threatening full-thickness or deep partial-thickness thermal injuries where sufficient autograft is not available at the time of excision or not desirable due to the physiological condition of the patient.


Reconstruction

INTEGRA Template is indicated for the repair of scar contractures when other therapies have failed, or when donor sites for repair are not sufficient or desirable due to the physiological condition of the patient.

 
Previous Previous | Next Next

© Copyright 2010 Integra LifeSciences Corporation. All Rights Reserved.
Terms of Use • Privacy Policy